Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT00871858
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed invasive breast cancer, meeting 1 of the following criteria:
* SBR grade I-II disease (patients \< 65 years of age)
* SBR grade I-III disease (patients \> 65 years of age)
* T2 (2-5 cm), T3, or T4B, and N0-1 disease
* No metastatic disease
* Breast lesion not amenable to breast-conserving resection
* No inflammatory breast cancer
* No prior breast cancer
* Hormone receptor status:
* Estrogen receptor- and/or progesterone receptor-positive
PATIENT CHARACTERISTICS:
* Postmenopausal
* No other cancer within the past 5 years except for adequately treated skin carcinoma or carcinoma in situ of the cervix
* No contraindication to anti-hormonal treatment
* No psychological, familial, social, or geographical reasons that would preclude follow up
PRIOR CONCURRENT THERAPY:
* At least 8 days since prior hormone replacement therapy
* No concurrent anti-vitamin K treatment
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT00871858
Study Brief:
Protocol Section:
NCT00871858